Status:
RECRUITING
Probiotics for Depression in Cancer Patients
Lead Sponsor:
Aristotle University Of Thessaloniki
Conditions:
Depression
Anxiety Disorder
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Anxiety and depressive disorders are quite prevalent in the general population. In 2015, it was estimated that 3.6% of the world population (around 264 million individuals) live with depression and 4....
Detailed Description
Based on the assumption that 1. at least one third of digestive cancer patients operated on - and probably more, when surgery is followed by chemotherapy sessions - suffer from anxiety and depression,...
Eligibility Criteria
Inclusion
- Age \>18 and \<85
- Histologically confirmed diagnosis of digestive tract malignancy, the tumor having been surgically resected and the patient currently undergoing chemotherapy sessions
- Informed consent obtained to participate in the study
Exclusion
- Not understanding the Greek language
- Dementia
- Pre-existing psychiatric disorders
- Already receiving probiotic supplements (apart from yoghurt)
- Participation in another clinical trial
- Consumption of less than the 90% of treatment sachets/doses (verified by the sachets returned)
- Those having received during hospitalization other probiotic formulations
Key Trial Info
Start Date :
November 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 15 2025
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT06496438
Start Date
November 15 2023
End Date
March 15 2025
Last Update
July 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AHEPA University Hospital
Thessaloniki, Greece, 54636